News India remains on US trade “priority watch list” for failing to uphold international drug company patents BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2949 (Published 08 May 2013) Cite this as: BMJ 2013;346:f2949 Article Related content Metrics Responses Peer review Related articles News Indian Supreme Court rejects Novartis’s appeal on drug patent Published: 02 April 2013; BMJ 346 doi:10.1136/bmj.f2099 News Bayer challenges India’s first compulsory licence for generic version of cancer drug Published: 06 September 2012; BMJ 345 doi:10.1136/bmj.e6015 News Roche’s decision to drop Herceptin patent in India opens way for generics Published: 19 August 2013; BMJ 347 doi:10.1136/bmj.f5197 Feature Patent wars: affordable medicines versus intellectual property rights Published: 17 February 2014; BMJ 348 doi:10.1136/bmj.g1533 Cited by... Patent wars: affordable medicines versus intellectual property rightsFulltext PDF Roche's decision to drop Herceptin patent in India opens way for genericsFulltext PDF
